Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeted therapies in myelodysplastic syndromes: ASH 2003 review.
Candoni A, Silvestri F, Buonamici S, Li D, Reddy P, Galili N, Nucifora G, Raza A. Candoni A, et al. Semin Hematol. 2004 Apr;41(2 Suppl 4):13-20. doi: 10.1053/j.seminhematol.2004.02.003. Semin Hematol. 2004. PMID: 15190511 Review.
Remicade as TNF suppressor in patients with myelodysplastic syndromes.
Raza A, Candoni A, Khan U, Lisak L, Tahir S, Silvestri F, Billmeier J, Alvi MI, Mumtaz M, Gezer S, Venugopal P, Reddy P, Galili N. Raza A, et al. Among authors: candoni a. Leuk Lymphoma. 2004 Oct;45(10):2099-104. doi: 10.1080/10428190410001723322. Leuk Lymphoma. 2004. PMID: 15370256 Clinical Trial.
Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression.
Raza A, Buonamici S, Lisak L, Tahir S, Li D, Imran M, Chaudary NI, Pervaiz H, Gallegos JA, Alvi MI, Mumtaz M, Gezer S, Venugopal P, Reddy P, Galili N, Candoni A, Singer J, Nucifora G. Raza A, et al. Among authors: candoni a. Leuk Res. 2004 Aug;28(8):791-803. doi: 10.1016/j.leukres.2003.11.018. Leuk Res. 2004. PMID: 15203277
Neutralizing anti-interferon-alpha antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (alpha 2a) and lymphoblastoid interferon-alpha.
Russo D, Candoni A, Zuffa E, Minisini R, Silvestri F, Fanin R, Zaja F, Martinelli G, Tura S, Botta G, Baccarani M. Russo D, et al. Among authors: candoni a. Br J Haematol. 1996 Aug;94(2):300-5. doi: 10.1046/j.1365-2141.1996.d01-1790.x. Br J Haematol. 1996. PMID: 8759890
Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma.
Silvestri F, Barillari G, Fanin R, Salmaso F, Pipan C, Falasca E, Puglisi F, Mariuzzi L, Zaja F, Infanti L, Patriarca F, Candoni A, Rogato A, Di Loreto C, Botta GA, Baccarani M. Silvestri F, et al. Among authors: candoni a. Ann Oncol. 1998 May;9(5):499-504. doi: 10.1023/a:1008265804550. Ann Oncol. 1998. PMID: 9653490 Free article.
254 results